Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5-/- mice

Journal of Bone and Mineral Research

Volumn 23, Issue 11, 2008, Pages 1815-1824

  Nijenhuis, Tom ^a   Van Der Eerden, Bram C J ^b   Hoenderop, Joost G J ^a   Weinans, Harrie ^b   Van Leeuwen, Johannes P T M ^b   Bindels, René J M ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

1,25(OH)2D3; Alendronate; Calcium; Osteoclast; TRPV5

Indexed keywords

ALENDRONIC ACID; CALCIUM ION; CARRIER PROTEIN; CHLORIDE CHANNEL; MEMBRANE PROTEIN; PARATHYROID HORMONE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; VANILLOID RECEPTOR 5; VITAMIN D;

ANALYTICAL PARAMETERS; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BONE; BONE ATROPHY; BONE MARROW CULTURE; BONE METABOLISM; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL VACUOLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; DUODENUM; FEMUR; GENE EXPRESSION; GENOTYPE; HORMONE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INTESTINE; KIDNEY; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NEWBORN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TISSUE CULTURE; TONOPLAST; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS; WILD TYPE;

ALENDRONATE; ANIMALS; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; BONE AND BONES; BONE MARROW CELLS; BONE RESORPTION; CALCIUM; CALCIUM CHANNELS; CELLS, CULTURED; CHLORIDE CHANNELS; DUODENUM; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; KIDNEY; MICE; OSTEOCLASTS; RNA, MESSENGER; TRPV CATION CHANNELS; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 54249120768     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.080613     Document Type: Article

References (50)

1. Hoenderop JG, Nilius B, Bindels RJ 2005 Calcium absorption across epithelia. Physiol Rev 85:373-422.
2. 2+ entry at the gate. Pflugers Arch 451:181-192.
3. Harada S, Rodan GA 2003 Control of osteoblast function and regulation of bone mass. Nature 423:349-355.
4. 2+ channel TRPV6 in the kidney. J Am Soc Nephrol 14:2731-2740.
5. 2+ wasting, hyperabsorption and reduced bone thickness in mice lacking TRPV5. J Clin Invest 112:1906-1914.
6. 2+ channel TRPV5 is essential for proper osteoclastic bone resorption. Proc Natl Acad Sci USA 102:17507-17512.
7. 2+ channel in 1, 25-dihydroxyvitamin unresponsive epithelia. J Biol Chem 274:8375-8378.
8. Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, Hediger MA 1999 Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem 274:22739-22746.
9. Lee GS, Lee KY, Choi KC, Ryu YH, Paik SG, Oh GT, Jeung EB 2007 Phenotype of a calbindin-D9k gene knockout is compensated for by the induction of other calcium transporter genes in a mouse model. J Bone Miner Res 22:1968-1978.
10. Kutuzova GD, Akhter S, Christakos S, Vanhooke J, Kimmel-Jehan C, Deluca HF 2006 Calbindin D(9k) knockout mice are indistinguishable from wild-type mice in phenotype and serum calcium level. Proc Natl Acad Sci USA 103:12377-12381.
11. Zheng W, Xie Y, Li G, Kong J, Feng JQ, Li YC 2004 Critical role of calbindin-D28k in calcium homeostasis revealed by mice lacking both vitamin D receptor and calbindin-D28k. J Biol Chem 279:52406-52413.
12. 2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 115:1651-1658.
13. 2+ transport proteins by parathyroid hormone. Kidney Int 68:1708-1721.
14. 2+ hyperabsorption in TRPV5 knockout mice. J Am Soc Nephrol 16:3188-3195.
15. Reszka AA, Rodan GA 2003 Mechanism of action of bisphosphonates. Curr Osteoporos Rep 1:45-52.
16. Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC 2000 Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88(12 Suppl):2961-2978.
17. Hoenderop JG, Muller D, Van Der Kemp AW, Hartog A, Suzuki M, Ishibashi K, Imai M, Sweep F, Willems PH, Van Os CH, Bindels RJ 2001 Calcitriol controls the epithelial calcium channel in kidney. J Am Soc Nephrol 12:1342-1349.
18. 2+ transporting proteins in the distal tubule. Kidney Int 64:555-564.
19. Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, Notarangelo LD, Vezzoni P, Villa A 2000 Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 25:343-346.
20. Cleiren E, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama T, deVernejoul MC, Van Hul W 2001 Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet 10:2861-2867.
21. Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ 2001 Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104:205-215.
22. +-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet 9:2059-2063.
23. 2+ channels in small intestine as studied by quantitative mRNA detection. Am J Physiol Gastroinstest Liver Physiol 285:G78-G85.
24. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
25. Pettersson U, Albagha OM, Mirolo M, Taranta A, Frattini A, McGuigan FE, Vezzoni P, Teti A, Van Hul W, Reid DM, Villa A, Ralston SH 2005 Polymorphisms of the CLCN7 Gene Are Associated With BMD in Women. J Bone Miner Res 20:1960-1967.
26. Henriksen K, Gram J, Schaller S, Dahl BH, Dziegiel MH, Bollerslev J, Karsdal MA 2004 Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am J Pathol 164:1537-1545.
27. Laitala-Leinonen T, Lowik C, Papapoulos S, Vaananen HK 1999 Inhibition of intravacuolar acidification by antisense RNA decreases osteoclast differentiation and bone resorption in vitro. J Cell Sci 112:3657-3666.
28. Suda T, Ueno Y, Fujii K, Shinki T 2003 Vitamin D and bone. J Cell Biochem 88:259-266.
29. 3 analogs to mice. J Endocrinol 165:163-172.
30. Marshall MJ, Wilson AS, Davie MW 1990 Effects of (3-amino-1- hydroxypropylidene)-1,1-bisphosphonate on mouse osteoclasts. J Bone Miner Res 5:955-962.
31. Holt I, Marshall MJ, Davie MW 1994 Pamidronate stimulates recruitment and decreases longevity of osteoclast nuclei in mice. Semin Arthritis Rheum 23:263-264.
32. Marshall MJ, Holt I, Davie MW 1993 Osteoclast recruitment in mice is stimulated by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate. Calcif Tissue Int 52:21-25.
33. van Beek ER, Lowik CW, Papapoulos SE 1997 Effect of alendronate treatment on the osteoclastogenic potential of bone marrow cells in mice. Bone 20:335-340.
34. Sato M, Grasser W 1990 Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J Bone Miner Res 5:31-40.
35. Breuil V, Cosman F, Stein L, Horbert W, Nieves J, Shen V, Lindsay R, Dempster DW 1998 Human osteoclast formation and activity in vitro: Effects of alendronate. J Bone Miner Res 13:1721-1729.
36. Endo Y, Nakamura M, Kikuchi T, Shinoda H, Takeda Y, Nitta Y, Kumagai K 1993 Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine synthesis and increase macrophages, granulocytes, and osteoclasts in vivo. Calcif Tissue Int 52:248-254.
37. Blair HC, Athanasou NA 2004 Recent advances in osteoclast biology cind pathological bone resorption. Histol Histopathol 19:189-199.
38. Gay CV, Weber JA 2000 Regulation of differentiated osteoclasts. Crit Rev Eukaryot Gene Expr 10:213-230.
39. +-ATPase type in the ruffled borders of osteoclasts. J Cell Biol 111:1305-1311.
40. Gay CV, Kief NL, Bekker PJ 1993 Effect of estrogen on acidification in osteoclasts. Biochem Biophys Res Commun 192:1251-1259.
41. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA 1991 Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88:2095-2105.
42. Watson PH, Fraher LJ, Hendy GN, Chung UI, Kisiel M, Natale BV, Hodsman AB 2000 Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues. J Bone Miner Res 15:1033-1044.
43. Sterling TM, Nemere I 2007 Calcium uptake and membrane trafficking in response to PTH or 25(OH)D3 in polarized intestinal epithelial cells. Steroids 72:151-157.
44. Gentili C, Morelli S, de Boland AR 2003 Characterization of PTH/PTHrP receptor in rat duodenum: Effects of ageing. J Cell Biochem 88:1157-1167.
45. Nemere I, Larsson D 2002 Does PTH have a direct effect on intestine? J Cell Biochem 86:29-34.
46. Karsdal MA, Henriksen K, Sorensen MG, Gram J, Schaller S, Dziegiel MH, Heegaard AM, Christophersen P, Martin TJ, Christiansen C, Bollerslev J 2005 Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption. Am J Pathol 166:467-476.
47. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T 1999 Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: Receptor activator of NF-kappa B ligand. Bone 25:517-523.
48. Martin TJ, Sims NA 2005 Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11:76-81.
49. Martin TJ, Ng KW 1994 Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem 56:357-366.
50. 3 and thyroid hormones. Cell Biol Int 27:459-468.